Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(R*)]]-

CAS No.
149839-65-6
Chemical Name:
Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(R*)]]-
Synonyms
Etoposide EP impurity R (S configuration);Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(...;Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(R*)]]-
CBNumber:
CB49812158
Molecular Formula:
C50H50O20
Molecular Weight:
970.93
MDL Number:
MOL File:
149839-65-6.mol
Last updated:2022-12-21 16:56:50

Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(R*)]]- Properties

Density 1.58±0.1 g/cm3(Predicted)
pka 9.94±0.40(Predicted)
FDA UNII SD2141W3YA

Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(R*)]]- Preparation Products And Raw materials

Raw materials

Preparation Products

Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(R*)]]- Suppliers

Global( 2)Suppliers
Supplier Tel Email Country ProdList Advantage
TOSUN PHARM 020-61855200 13326451905 2881290884@qq.com China 7524 58
Henan Vcommend Consultrading Co., Ltd. 13393721940 sales@vcommend.com China 9944 58
Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(R*)]]- Etoposide EP impurity R (S configuration) Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(... 149839-65-6